TEARLAB
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol TEAR and on the Toronto Stock Exchange under the symbol TLB.
TEARLAB
Industry:
Hardware Health Care Medical Device
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.tearlab.com
Total Employee:
101+
Status:
Active
Contact:
(858)812-0540
Email Addresses:
[email protected]
Total Funding:
54.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Euro IPv6 Cloudflare Network Error Logging Facebook Pixel
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Post-IPO Debt - TearLab
More informations about "TearLab"
TearLab - Crunchbase Company Profile & Funding
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The …See details»
Trukera Medical rebranding allows team to expand …
Oct 11, 2022 At Trukera Medical, we've recently rebranded our organization historically founded as TearLab, a one-product company focused on in vitro diagnostics to help advance corneal health and decision making. After nearly …See details»
TearLab® Announces Corporate Name Change to …
Sep 7, 2022 TearLab introduced osmolarity testing as an innovative, objective diagnostic tool in the eye care market with the TearLab Osmolarity System in 2010. The device has since become a routine and even ...See details»
TearLab Corporation Company Profile - Dun & Bradstreet
The diagnostics company has developed and commercialized the TearLab Osmolarity System, a tear collection and analysis system for use at the point of care. The system detects biomarkers …See details»
TearLab(R) Announces Corporate Name Change to …
Sep 8, 2022 The company’s current osmolarity testing has been used over 24 million times, with primary growth driven in cornea and premium cataract/refractive practices Trukera Medical is positioned to expand its …See details»
TearLab - Overview, News & Similar companies | ZoomInfo.com
Who is TearLab. TearLab Corporation operates as an in-vitro diagnostic company in the United States. It offers TearLab Osmolority System, a proprietary in vitro di agnostic tear testing …See details»
Tearlab Corp (TEAR) Profile - The Globe and Mail
Oct 20, 2007 See the company profile for Tearlab Corp (TEAR) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
TearLab rebrands as Trukera Medical - Healio
Sep 8, 2022 TearLab is changing its name to Trukera Medical.The name change reflects the company’s growth strategy of targeting a broader set of unmet corneal health needs while expanding its portfolio ...See details»
TearLab Corporation (TLB.TO) Company Profile & Facts - Yahoo …
See the company profile for TearLab Corporation (TLB.TO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
TearLab Company Profile - Office Locations, Competitors ... - Craft
Aug 23, 2021 TearLab has 5 employees at their 1 location and $22.66 m in annual revenue in FY 2019. See insights on TearLab including office locations, competitors, revenue, financials, …See details»
TearLab Announces Acquisition By Accelmed Partners And Related …
May 11, 2020 TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively …See details»
TearLab CEO Adam Szaronos on his first 180 days and the
May 11, 2022 TearLab has had a long journey getting to where we are right now. It’s taken a lot of sweat equity from many individuals to bring the company to this point, which is a huge …See details»
TearLab Positioned For Growth With Jim Mazzo Joining Board of …
Nov 9, 2021 The TearLab ® osmolarity test aids in the diagnosis Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Media Contact Shannon …See details»
TearLab Corporation Announces Adam Szaronos as President and …
Dec 9, 2021 The TearLab ® osmolarity test aids in the diagnosis Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Media Contact Shannon …See details»
TearLab How to Test - Trukera
TearLab How to Test. This video provides an overview of the TearLab Osmolarity System, and the methods for tear collection and testing. Trukera Resource Center. Trukera Portal Order …See details»
TearLab - touchOPHTHALMOLOGY
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease …See details»
TearLab® Osmolarity Test supports DED diagnosis - The …
Dec 5, 2021 The TearLab Osmolarity test has been used on 20 million eyes in 50 countries over the past decade – and it is predictive of DED 89 percent of the time (4). The test guides a …See details»
TearLab Dry Eye Test - Labtician Ophthalmics
TearLab ® Osmolarity System is an objective and quantitative point-of-care diagnostic test that provides precise and predictive information. TearLab ® is intended to measure the osmolarity …See details»
TearLab ® Osmolarity System for diagnosing dry eye
Jan 9, 2014 TearLab ® Osmolarity System ... The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial …See details»